# Development and Multicenter Validation of a Novel Bio-Anatomical Staging System for Predicting Survival and Tailoring Adjuvant Therapy in ESCC After Neoadjuvant Chemoimmunotherapy.

> **NCT07488624** · — · COMPLETED · sponsor: **Sichuan University** · enrollment: 414 (actual)

## Conditions studied

- ESCC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07488624
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 414 (ACTUAL)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07488624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07488624, "Development and Multicenter Validation of a Novel Bio-Anatomical Staging System for Predicting Survival and Tailoring Adjuvant Therapy in ESCC After Neoadjuvant Chemoimmunotherapy.". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT07488624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*